Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Berman currently holds 3,119 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Berman has been a net seller of BHVN stock. They have purchased $106.6K and sold $33.3M worth of shares.
Robert Berman's most recent insider trade was on Jul 8, 2020, when they sold 55,626 shares at $75.25 per share.
Robert Berman serves as Executive at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). They have executed 88 insider transactions totaling $33.4M over their tenure at the company.
Robert Berman holds the position of Executive at Biohaven Pharmaceutical Holding Co Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Robert Berman has shown a selling trading pattern, with $106.6K in total purchases and $33.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert Berman was on Jun 18, 2020, when they sold $4.5M worth of BHVN shares. This transaction involved 59,914 shares at $75.25 per share.
Robert Berman currently owns 3,119 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Berman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Berman has 88 Form 4 filings on record as an insider at Biohaven Pharmaceutical Holding Co Ltd..
Set alerts for Robert Berman and 40,000+ other insiders.